ClinChoice

Fort Washington, United States Founded: 1995 • Age: 31 yrs
CRO focused on data management, regulatory affairs and consulting services
Request Access

About ClinChoice

ClinChoice is a company based in Fort Washington (United States) founded in 1995 by John D Balian and Xin Ke.. ClinChoice has raised $212 million across 2 funding rounds from investors including Goldman Sachs, Taikang Insurance Group and Legend Capital. The company has 474 employees as of April 06, 2024. ClinChoice has completed 2 acquisitions, including CROMSOURCE and CSI Medical Research. ClinChoice offers products and services including Clinical Development, Post-Marketing Services, and Regulatory Affairs. ClinChoice operates in a competitive market with competitors including Emmes, Syneos Health, Veristat, Medelis WCCT Global and Celgene, among others.

  • Headquarter Fort Washington, United States
  • Employees 474 as on 06 Apr, 2024
  • Founders John D Balian, Xin Ke
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Clinchoice Private Limited
  • Date of Incorporation 20 Apr, 2013
  • Jurisdiction Bangalore, Karnataka, India
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
    $10.3 M (USD)
    35.19
    as on Mar 31, 2023
  • Net Profit
    $1.22 M (USD)
    100.61
    as on Mar 31, 2023
  • EBITDA
    $2.05 M (USD)
    67.34
    as on Mar 31, 2023
  • Total Equity Funding
    $212 M (USD)

    in 2 rounds

  • Latest Funding Round
    $150 M (USD), Series E

    Jul 04, 2022

  • Investors
  • Employee Count
    474

    as on Apr 06, 2024

  • Investments & Acquisitions
    CROMSOURCE

    & 1 more

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of ClinChoice

ClinChoice offers a comprehensive portfolio of products and services, including Clinical Development, Post-Marketing Services, and Regulatory Affairs. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Supports clinical trials and studies for drug development

Manages post-approval studies and evidence collection globally

Assists with regulatory compliance and strategic consulting

People of ClinChoice
Headcount 1000-5000
Employee Profiles 255
Employee Profiles
People
Ganapati Hegde
Senior Executive Regulatory Affairs
People
Syed Ibrahim Yaseen
Senior Executive Regulatory Affairs
People
Norayr Hakobyan
SAS Programmer/analyst
People
Tamar Pakhdikian
Regulatory Affairs Coordinator - Johnson&johnson

Unlock access to complete

Funding Insights of ClinChoice

ClinChoice has successfully raised a total of $212M across 2 strategic funding rounds. The most recent funding activity was a Series E round of $150 million completed in July 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round Series E — $150.0M
  • First Round

    (25 Oct 2019)

  • Investors Count 6
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2022 Amount Series E - ClinChoice Valuation Legend Capital
Oct, 2019 Amount Series D - ClinChoice Valuation Goldman Sachs
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in ClinChoice

ClinChoice has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Goldman Sachs, Taikang Insurance Group and Legend Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Venture Capital firm focused on multiple sectors
Founded Year Domain Location
-
Founded Year Domain Location
Apricot Capital is engaged in investing in impactful entrepreneurs.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by ClinChoice

ClinChoice has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include CROMSOURCE and CSI Medical Research. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Clinical research services for site management are provided.
2017
An ISO-certified CRO and provider of outsourced services to the pharmaceutical, biotechnology and medical device industries
1994
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - ClinChoice

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Clinchoice Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of ClinChoice

ClinChoice operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Emmes, Syneos Health, Veristat, Medelis WCCT Global and Celgene, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Outsourced contract research organization services are provided to clients.
domain founded_year HQ Location
CRO clinical development services are provided by Syneos Health.
domain founded_year HQ Location
Clinical trials and regulatory submissions are supported as a CRO.
domain founded_year HQ Location
Full-service CRO expertise in influenza and oncology research is offered.
domain founded_year HQ Location
Therapies for cancer and inflammatory diseases are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Clinchoice

Frequently Asked Questions about ClinChoice

When was ClinChoice founded?

ClinChoice was founded in 1995 and raised its 1st funding round 24 years after it was founded.

Where is ClinChoice located?

ClinChoice is headquartered in Fort Washington, United States. It is registered at Fort Washington, Maryland, United States.

Who is the current CEO of ClinChoice?

John D Balian is the current CEO of ClinChoice. They have also founded this company.

Is ClinChoice a funded company?

ClinChoice is a funded company, having raised a total of $212M across 2 funding rounds to date. The company's 1st funding round was a Series D of $62M, raised on Oct 25, 2019.

How many employees does ClinChoice have?

As of Apr 06, 2024, the latest employee count at ClinChoice is 474.

What is the annual revenue of ClinChoice?

Annual revenue of ClinChoice is $10.3M as on Mar 31, 2023.

What does ClinChoice do?

ClinChoice was established in 1995 and is based in Fort Washington, United States. As a contract research organization, focus is placed on data management, regulatory affairs, and consulting services within the pharmaceutical and biotechnology industries. Support is offered for clinical trial operations, compliance requirements, and strategic advisory needs across global markets. Co-founders include John D. Balian as CEO and Xin Ke.

Who are the top competitors of ClinChoice?

ClinChoice's top competitors include Emmes, Syneos Health and Veristat.

What products or services does ClinChoice offer?

ClinChoice offers Clinical Development, Post-Marketing Services, and Regulatory Affairs.

How many acquisitions has ClinChoice made?

ClinChoice has made 2 acquisitions, including CROMSOURCE, and CSI Medical Research.

Who are ClinChoice's investors?

ClinChoice has 6 investors. Key investors include Goldman Sachs, Taikang Insurance Group, Legend Capital, Sherpa Healthcare Partners, and Lilly Asia Ventures.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available